Also known as: Edurant; TMC278; R278474
Rilpivirine is a high-purity Active Pharmaceutical Ingredient (API) classified as a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) for HIV treatment. Mediocon Inc manufactures GMP-compliant Rilpivirine at its facility in Aurangabad, Maharashtra, India.
| Parameter | Specification |
|---|---|
| CAS Number | 132907-72-3 |
| Molecular Formula | C₂₂H₁₈N₆ |
| Molecular Weight | 366.42 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) / Antiretroviral |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | RLP/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Rilpivirine — CAS 132907-72-3 (CAS 132907-72-3) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Rilpivirine — CAS 132907-72-3 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance